Authors
Yueping Yao, Min Zhou, Zhihan Yan, Tingting Su, Huijing Fang, Xiujuan Yang, Xiaoye Guo
Published in
Computational biology and chemistry. Volume 125. Pages 109297. Aug 03, 2026. Epub Aug 03, 2026.
Abstract
While direct-acting antiviral (DAA) therapies effectively cure most chronic hepatitis C virus (HCV) infections, patients with pre-existing cirrhosis remain at risk for disease progression. Cellular senescence and immune dysregulation drive persistent liver injury post-clearance, but reliable biomarkers and therapeutic targets remain scarce.
Aging-related genes (ARGs) were integrated with differentially expressed genes and key WGCNA modules derived from the GSE14323 dataset, yielding 26 overlapping candidates. Hub genes were screened via protein-protein interaction and refined by LASSO, Random Forest, and Boruta. The diagnostic signature was validated in GSE14323 and GSE6764. Immune infiltration was assessed by CIBERSORT and ssGSEA, with molecular docking for drug screening.
Four hub genes (CTGF, FAS, GJA1, MMP7) were ultimately identified. The signature showed high diagnostic accuracy, achieving AUCs of 1.0 and 0.946 in the training and validation cohorts, respectively. HCV cirrhosis exhibited markedly altered immune infiltration profiles, and high-risk cases were significantly enriched for ECM remodeling, senescence, and TGFβ-SMAD signaling. The hub genes were closely correlated with immune- and fibrosis-related pathways. Furthermore, Marimastat, Obeticholic acid, and Pirfenidone showed strong binding to MMP7.
We established a novel ARG-based diagnostic signature for HCV cirrhosis, highlighting its association with immune remodeling and pathogenic pathways. Notably, MMP7 is a promising target, providing insights for post-clearance disease management.
PMID:
42556014
Bibliographic data and abstract were imported from PubMed on 06 Aug 2026.
Read full publication at:
Please sign in
to see all details.
Advertisement
Stats
- Recommendations n/a n/a positive of 0 vote(s)
- Views 1
- Comments 0